BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX)

Historical Holders from Q4 2021 to Q3 2025

Symbol
BRTX on Nasdaq
Type / Class
Equity / Common Stock, $0.0001 par value
Shares outstanding
8,896,104
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
379,488
Holdings value
$545,311
% of all portfolios
0%
Number of holders
14
Number of buys
8
Number of sells
-5
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ALSTODT LANCE 15.5% $2,189,152 1,236,809 ALSTODT LANCE 14 Feb 2025
Silva Francisco 15.1% $2,118,370 1,196,819 Silva, Francisco 14 Feb 2025
Auctus Fund Management LLC 9.9% 0% $1,224,062 +$39,886 784,655 +3.4% Auctus Fund, LLC 30 Jun 2025
Morrison Todd Hale 7.7% $856,250 +$856,250 685,000 Morrison Todd Hale 18 Dec 2025

Institutional Holders of BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 379,488 $545,311 +$177,417 $1.44 14
2025 Q2 247,366 $412,419 -$29,039 $1.67 15
2025 Q1 281,898 $501,776 +$4,468 $1.78 14
2024 Q4 281,569 $403,059 +$6,035 $1.43 15
2024 Q3 269,756 $467,517 +$33,580 $1.74 15
2024 Q2 249,324 $506,423 -$192,218 $2.03 13
2024 Q1 384,145 $529,717 +$97,349 $1.38 12
2023 Q4 288,523 $499,373 -$133,093 $1.74 12
2023 Q3 362,913 $648,980 +$64,128 $1.79 14
2023 Q2 322,631 $1,423,182 +$122,726 $4.41 13
2023 Q1 298,701 $1,015,948 -$33,505 $3.4 14
2022 Q4 324,307 $890,421 -$93,998 $2.75 15
2022 Q3 358,229 $1,154,000 +$89,064 $3.22 12
2022 Q2 330,106 $973,000 -$47,558 $2.95 10
2022 Q1 344,602 $1,801,000 -$260,513 $5.22 9
2021 Q4 396,349 $1,721,000 +$1,231,999 $4.35 8